04:35 PM EDT, 06/25/2025 (MT Newswires) -- Kymera Therapeutics ( KYMR ) shares fell over 5% during after-hours trading on Wednesday after the company said it commenced a public offering of $250 million of common shares and pre-funded warrants.

The company plans to offer underwriters a 30-day overallotment option to buy up to an additional $37.5 million common shares at the offering price, according to a statement.

Kymera plans to use the net proceeds to advance its preclinical and clinical degrader programs and for general corporate purposes, the company said.